DK2342566T3 - Fremgangsmåde til diagnosen af systemisk sclerodermia eller af pulmonær arteriel hypertension - Google Patents
Fremgangsmåde til diagnosen af systemisk sclerodermia eller af pulmonær arteriel hypertension Download PDFInfo
- Publication number
- DK2342566T3 DK2342566T3 DK09748405T DK09748405T DK2342566T3 DK 2342566 T3 DK2342566 T3 DK 2342566T3 DK 09748405 T DK09748405 T DK 09748405T DK 09748405 T DK09748405 T DK 09748405T DK 2342566 T3 DK2342566 T3 DK 2342566T3
- Authority
- DK
- Denmark
- Prior art keywords
- diagnosis
- procedure
- arterial hypertension
- pulmonary arterial
- systemic sclerodermia
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/10—Musculoskeletal or connective tissue disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/321—Arterial hypertension
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Biotechnology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Rheumatology (AREA)
- Rehabilitation Therapy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0856255A FR2936060B1 (fr) | 2008-09-17 | 2008-09-17 | Procede de diagnostic d'une sclerodermie systemique ou d'une hypertension arterielle pulmonaire. |
| PCT/FR2009/051753 WO2010031968A1 (fr) | 2008-09-17 | 2009-09-17 | Procédé de diagnostic d'une sclérodermie systémique ou d'une hypertension artérielle pulmonaire |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2342566T3 true DK2342566T3 (da) | 2015-05-04 |
Family
ID=40282523
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK09748405T DK2342566T3 (da) | 2008-09-17 | 2009-09-17 | Fremgangsmåde til diagnosen af systemisk sclerodermia eller af pulmonær arteriel hypertension |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20110311995A1 (da) |
| EP (1) | EP2342566B1 (da) |
| CA (1) | CA2737535A1 (da) |
| DK (1) | DK2342566T3 (da) |
| ES (1) | ES2535719T3 (da) |
| FR (1) | FR2936060B1 (da) |
| WO (1) | WO2010031968A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9474745B2 (en) * | 2011-05-02 | 2016-10-25 | The Board Of Trustees Of The Leland Stanford Junior University | Use of FK506 for the treatment of pulmonary arterial hypertension |
| WO2018138297A1 (en) | 2017-01-27 | 2018-08-02 | Kymab Limited | Anti-opg antibodies |
| US11413280B2 (en) | 2017-05-19 | 2022-08-16 | The Board Of Trustees Of The Leland Stanford Junior University | Enzastaurin and fragile histidine triad (FHIT)-increasing agents for the treatment of pulmonary hypertension |
| WO2019173215A1 (en) * | 2018-03-07 | 2019-09-12 | Timber Pharmaceuticals Llc | Compositions and methods for treating cutaneous fibrosis |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998002744A1 (fr) * | 1996-07-17 | 1998-01-22 | Kaneka Corporation | Medicaments pour le diagnostic de maladies auto-immunes |
| JP2010509598A (ja) * | 2006-11-13 | 2010-03-25 | ライフ テクノロジーズ コーポレーション | 前立腺癌バイオマーカーを検出するための方法およびキット |
| GB0721160D0 (en) * | 2007-10-29 | 2007-12-05 | Univ Leuven Kath | New method for diagnosing sjogren's syndrome |
| CA2725548A1 (en) * | 2008-05-09 | 2009-11-12 | Duke University | Autoantibodies in the detection and treatment of cancer |
-
2008
- 2008-09-17 FR FR0856255A patent/FR2936060B1/fr not_active Expired - Fee Related
-
2009
- 2009-09-17 WO PCT/FR2009/051753 patent/WO2010031968A1/fr active Application Filing
- 2009-09-17 ES ES09748405.9T patent/ES2535719T3/es active Active
- 2009-09-17 US US12/998,080 patent/US20110311995A1/en not_active Abandoned
- 2009-09-17 CA CA2737535A patent/CA2737535A1/fr not_active Abandoned
- 2009-09-17 DK DK09748405T patent/DK2342566T3/da active
- 2009-09-17 EP EP09748405.9A patent/EP2342566B1/fr not_active Not-in-force
-
2015
- 2015-04-14 US US14/686,190 patent/US20150323550A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| FR2936060A1 (fr) | 2010-03-19 |
| US20150323550A1 (en) | 2015-11-12 |
| EP2342566B1 (fr) | 2015-01-28 |
| CA2737535A1 (fr) | 2010-03-25 |
| FR2936060B1 (fr) | 2010-11-19 |
| EP2342566A1 (fr) | 2011-07-13 |
| US20110311995A1 (en) | 2011-12-22 |
| WO2010031968A1 (fr) | 2010-03-25 |
| ES2535719T3 (es) | 2015-05-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL300938I2 (nl) | Niraparib tosylaat of niraparib tosylaat monohydraat | |
| CY2016017I1 (el) | Συνθεση για θεραπεια πνευμονικης υπερτασης | |
| DK2231606T3 (da) | Fremgangsmåder til fremstilling af cycloalkylcarboxamidopyridinbenzoesyrer | |
| HK1217230A1 (zh) | 生物標誌物在評估從動脈高血壓向心力衰竭的早期轉變中的用途 | |
| DK2220021T3 (da) | Fremgangsmåde til fremstilling af terephtalsyre | |
| DK2114853T3 (da) | Fremgangsmåde til fremstilling af glycerolestere | |
| DK2231565T3 (da) | Fremgangsmåder til fremstilling af clorerede carbonhydrider | |
| DK2504451T3 (da) | Fremgangsmåder til at forudsige det kliniske forløb af cancer | |
| DE502007002411D1 (de) | Warmfeste Aluminiumlegierung | |
| DK1948176T3 (da) | Diarylurinstoffer til behandling af pulmonær hypertension | |
| BRPI0917491A2 (pt) | tratamento de hipertensao arterial pulmonar | |
| DK2513063T3 (da) | Fremgangsmåde til fremstilling af 1-alkyl-/1-aryl-5-pyrazolcarboxylsyrederivater | |
| NO2019021I1 (no) | Desmopressin eller et acetatsalt derav | |
| DK2378529T3 (da) | Sammensætning til dannelse af højdielektrisk film til filmkondensator | |
| DK2462098T3 (da) | Fremgangsmåde til fremstillingen af derivater af 1-(2-halobiphenyl-4-yl)-cyclopropancarboxylsyre | |
| CL2014002318A1 (es) | Procedimiento para la separación de ésteres de alquilo (divisional de solicitud n° 1387-2010) | |
| DK2124946T3 (da) | Anvendelse af N-methylpyridiniumderivater til hepatobeskyttelse | |
| DK2342566T3 (da) | Fremgangsmåde til diagnosen af systemisk sclerodermia eller af pulmonær arteriel hypertension | |
| DK3821891T3 (da) | Anvendelse af fk506 til behandlingen af pulmonal arteriel hypertension | |
| DK2493860T3 (da) | Fremgangsmåde til fremstilling af 4-sulfinylpyrazolderivater | |
| DK2516359T3 (da) | Fremgangsmåde til fremstilling af ethylbenzen | |
| DK2462108T3 (da) | Fremgangsmåde til fremstilling af pyrazolcarboxylsyreamider | |
| DK2323686T3 (da) | Adiponectin til behandling af lungesygdom | |
| ITMI20080195A1 (it) | Procedimento per la preparazione di solifenacin | |
| DK2387349T3 (da) | Fremgangsmåde til inspektion af indersiden af en snæver slange eller et snævert rør, især til medicinsk brug |